financetom
Business
financetom
/
Business
/
Why Retail Giant Kroger's Shares Are Moving Higher Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Retail Giant Kroger's Shares Are Moving Higher Today
Mar 7, 2024 7:05 AM

Kroger Company ( KR ) shares are rising after it reported fourth-quarter FY23 sales growth of 6.4% year-on-year to $37.064 billion, slightly missing the analyst consensus estimate of $37.112 billion.

Identical Sales without fuel decreased by 0.8%. Adjusted EPS of $1.34 and Adjusted EPS of $1.14, excluding the 53rd week, beat the consensus of $1.13.

Gross margin was 22.7%, and the FIFO gross margin rate, excluding fuel, increased by 13 basis points Y/Y.

Operating, general and administrative expenses rose 7.4% Y/Y to $6.3 billion. Operating margin expanded from 2.4% to 3.2%, and operating income for the quarter jumped 44.5% to $1.2 billion.

Kroger ( KR ) held $1.88 billion in cash and temporary cash investments as of February 3, 2024. Operating cash flow year-to-date totaled $6.78 billion. The company had a net total debt of $10.6 billion as of February 3, 2024.

“As customers manage macroeconomic pressures, we are lowering prices and offering even more ways to save with personalized promotions and rewards,” said Chairman and CEO Rodney McMullen.

Outlook: Kroger ( KR ) sees FY24 adjusted EPS of $4.30-$4.50 versus an estimate of $4.34.

Kroger ( KR ) now expects full-year identical sales without fuel to be 0.25%-1.75%, Adjusted FIFO operating profit of $4.6 billion-$4.8 billion and capital expenditure of $3.4 billion – $3.6 billion.

Price Action: KR shares are trading higher by 7.11% at $54.08 on the last check Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Springworks Therapeutics Insider Sold Shares Worth $801,372, According to a Recent SEC Filing
Springworks Therapeutics Insider Sold Shares Worth $801,372, According to a Recent SEC Filing
Jun 5, 2024
04:13 PM EDT, 06/05/2024 (MT Newswires) -- Badreddin Edris, Chief Operating Officer, on June 03, 2024, sold 20,000 shares in Springworks Therapeutics ( SWTX ) for $801,372. Following the Form 4 filing with the SEC, Edris has control over a total of 249,600 shares of the company, with 249,600 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465924068673/xslF345X03/tm2416457-1_4seq1.xml ...
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,115,422, According to a Recent SEC Filing
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,115,422, According to a Recent SEC Filing
Jun 5, 2024
04:13 PM EDT, 06/05/2024 (MT Newswires) -- Marion McCourt, Executive Vice President, Commercial, on June 03, 2024, sold 1,138 shares in Regeneron Pharmaceuticals ( REGN ) for $1,115,422. Following the Form 4 filing with the SEC, McCourt has control over a total of 13,105 shares of the company, with 12,931 shares held directly and 174 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/872589/000196820224000100/xslF345X03/edgardoc.xml...
Celldex Therapeutics Insider Sold Shares Worth $1,964,088, According to a Recent SEC Filing
Celldex Therapeutics Insider Sold Shares Worth $1,964,088, According to a Recent SEC Filing
Jun 5, 2024
04:14 PM EDT, 06/05/2024 (MT Newswires) -- Margo Heath-Chiozzi, Senior Vice President, Regulatory Affairs, on June 03, 2024, sold 58,369 shares in Celldex Therapeutics ( CLDX ) for $1,964,088. Following the Form 4 filing with the SEC, Heath-Chiozzi has control over a total of 13,383 shares of the company, with 13,383 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/xslF345X03/form4-06052024_080636.xml ...
--ChargePoint Guides For Q2 Revenue of $108-$118 Million, vs CIQ Analyst Consensus of $123 Million
--ChargePoint Guides For Q2 Revenue of $108-$118 Million, vs CIQ Analyst Consensus of $123 Million
Jun 5, 2024
04:13 PM EDT, 06/05/2024 (MT Newswires) -- Price: 1.7700, Change: +0.05, Percent Change: +2.91 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved